Mutual of America Capital Management LLC Buys 55 Shares of Axon Enterprise, Inc $AXON

Mutual of America Capital Management LLC grew its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 0.5% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,144 shares of the biotechnology company’s stock after purchasing an additional 55 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Axon Enterprise were worth $8,399,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in AXON. Brighton Jones LLC bought a new position in Axon Enterprise in the 4th quarter worth $480,000. GAMMA Investing LLC raised its holdings in Axon Enterprise by 11.8% in the 1st quarter. GAMMA Investing LLC now owns 1,454 shares of the biotechnology company’s stock worth $765,000 after purchasing an additional 154 shares in the last quarter. Blue Trust Inc. raised its holdings in Axon Enterprise by 33.1% in the 1st quarter. Blue Trust Inc. now owns 169 shares of the biotechnology company’s stock worth $89,000 after purchasing an additional 42 shares in the last quarter. Heartland Bank & Trust Co bought a new position in Axon Enterprise in the 1st quarter worth $307,000. Finally, Kentucky Retirement Systems grew its position in shares of Axon Enterprise by 0.4% in the 1st quarter. Kentucky Retirement Systems now owns 4,953 shares of the biotechnology company’s stock worth $2,605,000 after buying an additional 19 shares during the period. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $683.13 on Tuesday. Axon Enterprise, Inc has a one year low of $422.38 and a one year high of $885.91. The company’s 50-day moving average is $736.73 and its 200 day moving average is $720.91. The company has a market capitalization of $53.63 billion, a price-to-earnings ratio of 168.67, a price-to-earnings-growth ratio of 26.04 and a beta of 1.41. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, beating the consensus estimate of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The company had revenue of $668.54 million for the quarter, compared to the consensus estimate of $641.77 million. During the same period in the prior year, the firm posted $1.20 EPS. Axon Enterprise’s revenue for the quarter was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. Sell-side analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Analysts Set New Price Targets

AXON has been the topic of a number of recent research reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Axon Enterprise in a research report on Wednesday, October 8th. Bank of America upped their target price on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. Morgan Stanley set a $885.00 target price on shares of Axon Enterprise and gave the stock an “overweight” rating in a research report on Friday, July 11th. UBS Group reaffirmed a “neutral” rating and issued a $840.00 target price (up from $820.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. Finally, Northland Securities set a $800.00 target price on shares of Axon Enterprise in a research report on Tuesday, August 5th. Fourteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus target price of $841.64.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, CAO Jennifer H. Mak sold 77 shares of the company’s stock in a transaction dated Monday, September 15th. The shares were sold at an average price of $760.00, for a total transaction of $58,520.00. Following the transaction, the chief accounting officer owned 15,003 shares in the company, valued at approximately $11,402,280. This represents a 0.51% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $713.74, for a total transaction of $7,137,400.00. Following the transaction, the chief executive officer owned 3,033,982 shares in the company, valued at $2,165,474,312.68. This represents a 0.33% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 59,932 shares of company stock worth $45,115,616 in the last ninety days. 5.70% of the stock is currently owned by company insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.